Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection (tearing) and death in childhood. Currently ...

We have identified the gene that, when activated, initiates the developmental programme that results in cells forming a human ...

What if you could precisely change the genome of a pre-implantation human embryo and then safely use that embryo to try to ...

The EU has relaxed its rules on gene-editing. Now, only some gene-edited crops are regulated by the stringent GMO directive.

Human cells that have been edited with the new retron-based gene editing technology. Orange dots mark successful gene edits. Green dots show a fluorescent protein tag on the surface of mitochondria.

One company dominates with an approved therapy, while the other bets on in vivo innovation. See how their financials and risk profiles stack up for 2026.

A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects for millions living with complex inherited diseases, such as cystic ...

Researchers from the Department of Biomedical Engineering at UNIST and the Center for Genomic Integrity at the Institute for Basic Science (IBS) have announced an advance in cancer gene therapy. Their ...

It has also aggressively invested in gene editing, including its 2025 acquisition of cardiovascular disease gene-editing ...

Altering a single gene in human embryonic cells has revealed that NANOG plays a key role in early embryo development, ...